The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Hyperlipoproteinemia Type V

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Hyperlipoproteinemia Type V


High impact information on Hyperlipoproteinemia Type V


Chemical compound and disease context of Hyperlipoproteinemia Type V


Anatomical context of Hyperlipoproteinemia Type V


Gene context of Hyperlipoproteinemia Type V


  1. Increased risk for vitamin A toxicity in severe hypertriglyceridemia. Ellis, J.K., Russell, R.M., Makrauer, F.L., Schaefer, E.J. Ann. Intern. Med. (1986) [Pubmed]
  2. Eucaloric substitution of medium chain triglycerides for dietary long chain fatty acids in acquired total lipodystrophy: effects on hyperlipoproteinemia and endogenous insulin resistance. Wilson, D.E., Chan, I.F., Stevenson, K.B., Horton, S.C., Schipke, C. J. Clin. Endocrinol. Metab. (1983) [Pubmed]
  3. Primary type V hyperlipoproteinemia in childhood. Yeshurun, D., Chung, H., Gotto, A.M., Taunton, O.D. JAMA (1977) [Pubmed]
  4. Dietary treatment of type V hyperlipoproteinemia fails to normalize low levels of high-density lipoprotein cholesterol. Falko, J.M., Witztum, J.L., Schonfeld, G., Bateman, J. Ann. Intern. Med. (1979) [Pubmed]
  5. Distribution of cyclosporine in blood of a renal-transplant recipient with type V hyperlipoproteinemia. Verrill, H.L., Girgis, R.E., Easterling, R.E., Malhi, B.S., Mueller, W.F. Clin. Chem. (1987) [Pubmed]
  6. Presence of two forms of apolipoprotein B in patients with dyslipoproteinemia. Meng, M.S., Gregg, R.E., Schaefer, E.J., Hoeg, J.M., Brewer, H.B. J. Lipid Res. (1983) [Pubmed]
  7. Fenofibrate in type IV and type V hyperlipoproteinemia. Seidehamel, R.J. Cardiology (1989) [Pubmed]
  8. Activation of adipose tissue lipoprotein lipase by lipoprotein fractions from normals and patients with type v hyperlipoproteinemia. Lisch, H.J., Patsch, W., Riedler, L., Sailer, S., Braunsteiner, H. Klin. Wochenschr. (1978) [Pubmed]
  9. Measurement of two plasma triglyceride lipases by an immunochemical method: studies in patients with hypertriglyceridemia. Greten, H., DeGrella, R., Klose, G., Rascher, W., de Gennes, J.L., Gjone, E. J. Lipid Res. (1976) [Pubmed]
  10. High-density lipoprotein turnover. Nestel, P.J. Am. Heart J. (1987) [Pubmed]
  11. Abnormal preponderance of sialylated apolipoprotein CIII in triglyceride rich lipoproteins in type V hyperlipoproteinemia. Kashyap, M.L., Hynd, B.A., Robinson, K., Gartside, P.S. Metab. Clin. Exp. (1981) [Pubmed]
  12. Type V hyperlipoproteinemia in systemic lupus erythematosus. Nakane, T., Asayama, K., Higashida, K., Hayashibe, H., Uchida, N., Dobashi, K., Kodera, K., Tandou, T., Furuich, Y., Nakazawa, S. Pediatrics international : official journal of the Japan Pediatric Society. (2003) [Pubmed]
  13. Severe acute pancreatitis associated with hyperlipidemia: report of two cases and review of the literature in Japan. Ohmoto, K., Neishi, Y., Miyake, I., Yamamoto, S. Hepatogastroenterology (1999) [Pubmed]
WikiGenes - Universities